# May Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/may-health

- Industry: Medical Devices & Equipment
- Headquarters: Paris, France
- Website: www.mayhealth.com
- Total disclosed funding: $36M
- Latest round: Series B (May 13, 2024)
- Investors on record: 5

## About

Founded in 2017 and based in Paris, France, May Health US Inc., trading under the name May Health, operates as a clinical-stage medical device company. In March 2026, May Health US Inc. raised EUR 10 million in growth capital funding from  Sofinnova Partners, Trill Impact, Bpifrance Investissement and Nexpring Health. As of 2024, the company is led by its CEO, Anne Morrissey.

May Health develops treatment options for women suffering from polycystic ovary syndrome (PCOS). The firm offers ovarian rebalancing, which is a treatment that aims to restore ovulation through targeted ovarian ablation.

The company will use the March 2026 funding to complete its pivotal United States Investigational Device Exemption trial and support European launch planning for its Anavi System.

## Funding rounds

- Series B, May 13, 2024, $25M — Sofinnova Partners, Bpifrance Investissement, Trill Impact, Avestria Ventures, Kidron Capital Assets
- Series A, Dec 2, 2021, $5.7M — Sofinnova Partners
- Series A, Oct 21, 2019, $5.6M — Sofinnova Partners

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A, Series B
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Series B
- Trill Impact (https://capitalatlas.ai/funds/trill-impact) — Series B
- Avestria Ventures (https://capitalatlas.ai/funds/avestria-ventures) — Series B
- Kidron Capital Assets (https://capitalatlas.ai/funds/kidron-capital-assets) — Series B